Latest news
Loading news…
GliaPharm
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Geneva, Geneve, Switzerland Founded 2016 1-10 employees For Profit
GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
13
2 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 43
- Patents granted
- 13
- Trademarks
- 2
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $370K
Company Info
- Founded
- 2016
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 10
- HQ
- Geneva, Geneve, Switzerland
- Region
- Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 2.2
- Trend (30d)
- 1
- Trend (90d)
- 0.6
Key People at GliaPharm
Chief Scientific Officer, Co-founder
Co-CEO, OPERATING & TECHNOLOGY & Co-Founder
CO-CEO, FINANCE & BUSINESS DEVELOPMENT, CO-FOUNDER
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to GliaPharm
Loading news…
FAQs about GliaPharm
People who checked this page also checked these
Browse the full Acquirezy directory.